These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6789432)
21. [Ergotism of therapeutic origin. A report of 4 new cases (author's transl)]. Larcan A; Lambert H; Perrin M; Durand L; Long FX; Brice M; Leveau J J Mal Vasc; 1980; 5(1):29-33. PubMed ID: 7462817 [TBL] [Abstract][Full Text] [Related]
22. Lower extremity ischemia due to combined drug therapy for migraine. Greenberg DJ; Hallett JW Postgrad Med; 1982 Oct; 72(4):103-5, 107. PubMed ID: 6812034 [TBL] [Abstract][Full Text] [Related]
23. ['Only ergotamine still works']. Boom AJ Ned Tijdschr Geneeskd; 1991 Oct; 135(43):2040. PubMed ID: 1944672 [No Abstract] [Full Text] [Related]
24. Anorectal ulcers as a complication of migraine therapy. Eigler FW; Schaarschmidt K; Gross E; Richter HJ J R Soc Med; 1986 Jul; 79(7):424-6. PubMed ID: 3091821 [No Abstract] [Full Text] [Related]
28. [Apropos of a case of severe ischemia of the legs caused by ergotamine tartrate]. Basilico V; Griffa B; Lanza A; Meroni R; Clerici D Minerva Chir; 1987 Mar; 42(6):503-6. PubMed ID: 3112644 [No Abstract] [Full Text] [Related]
29. Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Tfelt-Hansen P; Olesen J Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):69-72. PubMed ID: 6784444 [TBL] [Abstract][Full Text] [Related]
30. [Ergotism. A case report and review of the literature]. Ruano-Calderón LA; Zermeño-Pohls F Rev Neurol; 2005 Apr 1-15; 40(7):412-6. PubMed ID: 15849674 [TBL] [Abstract][Full Text] [Related]
32. [Antimigrainous agents. General considerations and treatment of the crisis]. Massiou H; Bousser MG Rev Prat; 1986 Jan; 36(5):193-8. PubMed ID: 2870557 [No Abstract] [Full Text] [Related]
33. [Dihydroergocristine methanesulfonate: treatment of a severe case of perypheral ischemia induced by ergotamine tartrate]. Setti M; Nespoli M; Losapio GM Angiologia; 1978; 30(3):98-102. PubMed ID: 207203 [No Abstract] [Full Text] [Related]
34. [Non-tropical sprue and chronic inflammatory rectal stenosis in a patient with abuse of ergotamine-containing suppositories]. Himmelreich G; Riess H; Kretschmer R; Hopf U Z Gastroenterol; 1991 Jan; 29(1):31-5. PubMed ID: 1905444 [TBL] [Abstract][Full Text] [Related]
35. [Distal mesenteric arteritis: a rare complication of D. methylsergide treatment (author's transl)]. Utzmann O; Barret F; Cassan P; Bacourt F; Chatel A; Bigot JM J Radiol; 1981 Apr; 62(4):257-61. PubMed ID: 6790701 [TBL] [Abstract][Full Text] [Related]
37. [Use of ergotamine tartrate as a suppository in migraine]. Dalsgaard-Nielsen T Nord Med; 1968 Jul; 80(29):942-4. PubMed ID: 5685659 [No Abstract] [Full Text] [Related]
38. Myocardial infarction following administration of sublingual ergotamine. Klein LS; Simpson RJ; Stern R; Hayward JC; Foster JR Chest; 1982 Sep; 82(3):375-6. PubMed ID: 7105868 [No Abstract] [Full Text] [Related]
39. Ergot poisoning in paraplegia. Lenger R Paraplegia; 1984 Feb; 22(1):42-4. PubMed ID: 6425786 [TBL] [Abstract][Full Text] [Related]
40. Recognition and management of migraine. Wilkinson M Practitioner; 1983 Mar; 227(1377):357-61. PubMed ID: 6412225 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]